SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-19-044256
Filing Date
2019-08-02
Accepted
2019-08-02 16:26:05
Documents
1
Period of Report
2019-07-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3935
  Complete submission text file 0001209191-19-044256.txt   5408
Mailing Address C/O KING PHARMACEUTICALS, INC. 501 FIFTH STREET BRISTOL TN 37620
Business Address
Carter Eric G (Reporting) CIK: 0001387660 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36579 | Film No.: 19996322

Mailing Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025
Business Address 1035 O'BRIEN DRIVE MENLO PARK CA 94025 650-272-6269
Adverum Biotechnologies, Inc. (Issuer) CIK: 0001501756 (see all company filings)

IRS No.: 205258327 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)